Cathie Wood’s ARK Invest Buys Over 750,000 Shares of Ginkgo Bioworks

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Tuesday. Specifically, this fund bought roughly $7.3 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of this fund was down slightly on Tuesday.

ARK Innovation ETF (NYSEARCA: ARKK) bought 764,703 shares of Ginkgo Bioworks. At Tuesday’s closing price, this would have valued the sale at roughly $7.3 million. Even though this is a small fraction of their total holdings, every little bit counts. The Innovation ETF is down over 23% in the past year.

Check out all the ARK Invest purchases for Tuesday as well:

FundTickerNameShares
ARKFTCSLITCS GROUP73,600
ARKFDSYSJDISCOVERY29,478
ARKGVCYTVERACYTE45,700
ARKGSLGCSOMALOGIC187,013
ARKGSDGRSCHRODINGER12,216
ARKGQSIQUANTUM-SI51,318
ARKGPSNLPERSONALIS100,496
ARKGNTLAINTELLIA THERAPEUTICS20,655
ARKGMASS908 DEVICES20,047
ARKGFATEFATE THERAPEUTICS196,581
ARKGACCDACCOLADE116,240
ARKGBLIBERKELEY LIGHTS44,000
ARKKSSYSSTRATASYS72,471
ARKKNVTAINVITAE18,000
ARKKNTLAINTELLIA THERAPEUTICS8,433
ARKKMTLSMATERIALISE32,775
ARKKDNAGINKGO BIOWORKS764,703
ARKQXPEVXPENG97,697
ARKQVUZIVUZIX32,182
ARKQBLDEBLADE AIR MOBILITY44,068
ARKWCOINCOINBASE GLOBAL11,761
ARKWEDRENDEAVOR GROUP177,885
ARKWVCYTVERACYTE50,910
ARKWROKUROKU7,188
ARKXAVAVAEROVIRONMENT16,273
ARKXGRMNGARMIN8,728
ARKXMYNAMYNARIC4,707

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: Why This Wall Street Firm Is Still Very Bullish on Semiconductors for 2022


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article